Immunoprecise Antibodies Ltd Cash Flow Quality Index
Immunoprecise Antibodies Ltd cash flow quality index. Immunoprecise Antibodies Ltd (IPA) has a Cash Flow Quality Index of 0.11x as of October 2016. Operating cash flow of $11.17K is below net income of $101.16K, suggesting accrual-heavy earnings not yet converted to cash. See Immunoprecise Antibodies Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Immunoprecise Antibodies Ltd (2006–2016)
Cash flow quality index of Immunoprecise Antibodies Ltd from 2006 to 2016. Historical Cash Flow Quality Index for Immunoprecise Antibodies Ltd across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore IPA operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Immunoprecise Antibodies Ltd Cash Flow Quality Index by Year (2006–2016)
Immunoprecise Antibodies Ltd cash flow quality index by year from 2006 to 2016. Year-by-year earnings quality comparison for Immunoprecise Antibodies Ltd. For the full cash flow conversion analysis, see Immunoprecise Antibodies Ltd (IPA) cash conversion ratio.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2016 | 1.88x | $284.09K | $151.03K | ▲ +380.3% |
| 2014 | -0.67x | $-46.60K | $69.44K | ▼ -1.0% |
| 2006 | -0.66x | $-110.59K | $166.48K | — |